Product Mix Shift Through Total Quality Assurance Strategy
Intertek hit a record 17.4% operating margin in FY2024 by shifting to Total Quality Assurance mix.
Intertek Group, a Large Enterprise Testing, Inspection & Certification company, created value through Product Mix Shift.
In FY2018, Intertek Group generated revenue of GBP 2,801 million across three divisions — Products, Trade, and Resources — with Products contributing 77% of adjusted operating profit. Adjusted operating profit was GBP 482 million at a record 17.2% adjusted operating margin. Organic revenue growth was 3.7% at constant currency. However, a significant portion of revenue was transactional (one-off testing or inspection jobs with no contractual commitment), creating revenue volatility and pricing pressure. The company's Assurance services — enterprise-wide quality assurance programs — represented just 16% of group revenues, having doubled from 10% in 2015. Free cash flow was GBP 350.6 million with 126% cash conversion.
Under CEO André Lacroix (appointed 2015), Intertek pursued its Total Quality Assurance (TQA) strategy to shift the revenue mix from transactional testing toward higher-value, multi-year contractual assurance programs:
| Metric | FY2018 | FY2024 |
|---|---|---|
| Total revenue | GBP 2,801M | GBP 3,393M (+21%) |
| Adjusted operating profit | GBP 482M | GBP 590M (+22%) |
| Adjusted operating margin | 17.2% (record) | 17.4% (new record) |
| ROIC | — | 22.4% |
| Adjusted free cash flow | GBP 350.6M | GBP 408.8M (+17%) |
| Dividend per share | 99.1p | 156.5p (+58%) |
| Assurance as % of revenue (2015→2018) | 10% → 16% | growing |
Margin dipped to 16.3% in FY2022 (COVID disruption) before recovering to 16.6% (FY2023) and 17.4% (FY2024) — surpassing the prior FY2018 record. ROIC of 22.4% in FY2024 reflects capital discipline alongside the mix improvement.
Intertek's Total Quality Assurance strategy is a contract structure argument, not a product argument. The tests Intertek performs — product safety, materials analysis, chemical compliance — are technically interchangeable with those of Bureau Veritas, SGS, or any accredited competitor. What is not interchangeable is a multi-year master service agreement covering a client's entire supply chain across multiple testing categories, with dedicated account management, standardized reporting integrated into the client's procurement systems, and cross-divisional service bundling. A client who sources product safety tests from three different labs can switch any one of them with a phone call. A client running an enterprise assurance program through Intertek has their compliance workflows, supplier databases, and audit schedules embedded in a single relationship.
The Assurance segment growing from 10% to 16% of revenue between 2015 and 2018 represents the early conversion of transactional relationships into contractual ones. The margin benefit is visible in the FY2024 result: 17.4% adjusted operating margin — a new record, surpassing even the pre-COVID 17.2% — on a revenue base that grew 21% over six years. A business running at record margins six years into a strategy that explicitly deprioritized commodity transactional work has demonstrated that the mix shift is real, not just a labeling change.
ROIC of 22.4% is the capital discipline proof. Running enterprise assurance programs doesn't require proportional capital investment relative to transactional volume growth — the lab infrastructure already exists, the cross-sell happens within accounts already served, and the switching cost improvement reduces churn without additional investment. The 58% dividend per share growth confirms that the mix shift generated distributable cash rather than consuming it in reinvestment.
M&A-Driven Customer Acquisition in a Fragmented TIC Market
Market Entry Through Acquisitive Laboratory Network Expansion
Digital Quality Management System Driving Margin Recovery Across Five Business Lines